FDA Inspection 1271181 — Sanford Reproductive Medicine
The FDA completed an inspection of Sanford Reproductive Medicine on Apr 30, 2025 in Fargo, ND. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Apr 30, 2025
- Fiscal Year
- 2025
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Fargo, ND (United States)